Β2-agonist in patients with chronic obstructive pulmonary disease
The pathogenesis of chronic obstructive pulmonary disease (COPD) is explained by chronic inflammation leading to bronchial obstruction. The mechanism of COPD determines the key role of bronchodilators in the basic therapy of the disease, among which β2-agonists occupy an important place.